Showing results (131-140 of 312) with videos related to
Sort By:
Pageof 32
Current Opinion in Cardiology|May 7, 2020
Multifocal arterial disease: clinical implications and managementK I Paraskevas, G Geroulakos, F J Veith, et al.Current Medical Research and Opinion|June 18, 2004
Uric acid levels and vascular diseaseS S Daskalopoulou, V G Athyros, M Elisaf, et al.International Angiology : a Journal of the International Union of Angiology|September 5, 2001
The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular diseasesM Neagu, G Manda, C Constantin, et al.Current Pharmaceutical Design|October 29, 2009
Drug combinations for dyslipidemia and obesity treatment in metabolic syndromeM Florentin, M S Elisaf, D P Mikhailidis, et al.Current Medical Research and Opinion|February 23, 2008
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemiaM Florentin, E N Liberopoulos, D P Mikhailidis, et al.Microcirculation, Endothelium, and Lymphatics|February 1, 1988
The effect of cooling on in vitro vascular prostacyclin and platelet thromboxane A2 synthesis: relevance to cold-induced pathologyJ Y Jeremy, D P Mikhailidis, R A Hutton, et al.Current Medical Research and Opinion|May 23, 2002
MUSE: clinical experienceM A Khan, M Raistrick, D P Mikhailidis, et al.Current Medical Research and Opinion|April 7, 2005
CARDS on the table: should everybody with type 2 diabetes take a statin?J D Lee, J R Morrissey, D P Mikhailidis, et al.Current Pharmaceutical Design|July 20, 2005
The predictive value of lipid markers in vascular diseaseH J Milionis, S S Daskalopoulou, M Elisaf, et al.Clinical Science (London, England : 1979)|February 1, 1982
Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism?D P Mikhailidis, A M Mikhailidis, M L Woollard, et al.Pageof 32